Skip to main content

Peer Review reports

From: Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

Original Submission
4 Jan 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
31 Jan 2023 Reviewed Reviewer Report
14 Feb 2023 Reviewed Reviewer Report
23 Feb 2023 Author responded Author comments - Jing Zhong
Resubmission - Version 3
23 Feb 2023 Submitted Manuscript version 3
25 Feb 2023 Author responded Author comments - Jing Zhong
Resubmission - Version 4
25 Feb 2023 Submitted Manuscript version 4
20 Mar 2023 Reviewed Reviewer Report
4 Apr 2023 Reviewed Reviewer Report
7 Apr 2023 Author responded Author comments - Jing Zhong
Resubmission - Version 5
7 Apr 2023 Submitted Manuscript version 5
9 Apr 2023 Author responded Author comments - Jing Zhong
Resubmission - Version 6
9 Apr 2023 Submitted Manuscript version 6
12 Apr 2023 Author responded Author comments - Jing Zhong
Resubmission - Version 7
12 Apr 2023 Submitted Manuscript version 7
Publishing
14 Apr 2023 Editorially accepted
26 May 2023 Article published 10.1186/s12871-023-02092-2

You can find further information about peer review here.

Back to article page